Alirocumab vs Atezolizumab

## Alirocumab vs Atezolizumab: Overview

This comparison examines the pharmacological differences between **Alirocumab** and **Atezolizumab**.

## Mechanism of Action

**Atezolizumab**: Fully human anti-PD-L1 IgG1 monoclonal antibody blocking PD-L1 interaction with PD-1 and B7.1.

## Pharmacokinetics

**Half-life**: Alirocumab — N/A; Atezolizumab — 27 days.

## Chemical Properties

**Type**: Alirocumab — Antibody; Atezolizumab — Antibody.